Please login to the form below
drug side effects
This page shows the latest drug side effects news and features for those working in and with pharma, biotech and healthcare.
MSD launches antibiotic combo Recarbrio in UK
The result was particularly significant, given that colistin is often reserved as a ‘last-line’ therapeutic for Gram-negative infections, although the drug can have significant side-effects including kidney damage. ... According to the World Health
Latest news
-
Sobi’s Gamifant receives final rejection from CHMP for primary HLH
drug’s side effects. ... Gamifant was approved by the US Food and Drug Administration (FDA) for the treatment of primary HLH in November 2018.
-
AbbVie signs immunotherapy pact with I-Mab worth $2bn
In addition, I-Mab will receive a milestone payment of $20m based on results from phase 1 studies of the drug. ... Lemzoparlimab is designed to minimise binding to normal red blood cells while also demonstrating strong anti-tumour activity, which helps
-
Nektar’s opioid analgesic slammed with FDA panel rejection
High levels of euphoric side-effects from opioid medications have lead to abuse and addiction, which has caused a healthcare crisis to erupt across the US. ... Nektar’s drug avoids these side-effects because – according to the company – its
-
FDA clears SK Life Science’s anti-epileptic drug Xcopri
Significantly reduced the frequency of seizures at all doses studied. Korea-based SK Life Sciences has scored approval from the FDA in the US for its anti-epileptic drug Xcopri, as ... The safety profile of the anti-epilepsy drug does include side
-
Servier faces manslaughter trial over weight loss drug deaths
Lawyers representing the 2, 684 plaintiffs claim that Servier and the ANSM allowed the drug to remain on the market even though its side effects had been known for several years, ... The side effects caused by Mediator were uncovered by French
More from news
Approximately 1 fully matching, plus 110 partially matching documents found.
Latest Intelligence
-
Where next in Alzheimer’s disease R&D?
Much of this research centred on improving the selectivity of compounds so that they hit the target, M1, without also interacting with similar receptors linked to the intolerable side effects. ... Meanwhile, Karuna Pharmaceuticals has raised $42m to
-
Redirecting your patient strategy
But when people are dealing with their condition for so long, it is important that you understand how they're actually managing it, how they're using the drug.”. ... These new companies have developed novel business models based on sharing the data and
-
Choices, choices: the rapidly evolving HIV treatment landscape
IIs are more potent, with fewer side effects and drug interactions and the top reason for prescribing them is their good tolerability profile. ... As patients differ so do their barriers to adherence, whether this be complexity of the dosing regimen,
-
Patients First
to their thoughts on the impact of drug side effects, these are all areas that pharma is already actively engaged with at some level.
-
Oncology drugs under AMNOG: part two
The G-BA assesses drugs on four criteria: mortality; morbidity (for example, symptom improvement); quality of life; and adverse events (toxicity and side effects). . ... A natural question to ask is how the benefit finding impacts the final price of a
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
My MS journey: one patient's search for innovation
I’ve also seen a neuro-urologist who deals with bladder problems. The problem is, each specialist may give you a drug which can have unpleasant side effects, causing another layer
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- AZ sells stake in Moderna for around $1.2bn
- Syneos Health Communications announces senior hires to Europe-based team
- First shipments of AZ/Oxford COVID-19 vaccine sent through COVAX
- Merck & Co to help produce J&J’s COVID-19 vaccine in the US
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Andi Goes – the children’s book that helps detect early signs of dyslexia
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
